Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Shares Fall on Report of Q1 Foreign Exchange Losses

NEW YORK (GenomeWeb News) – Shares of Bruker dropped roughly 23 percent in late Tuesday afternoon trade, a day after the firm said that based on preliminary data it expects to report pre-tax foreign exchange losses of around $12 million for its first quarter ended March 31.
 
The Billerica, Mass.-based firm said that the foreign exchange losses were due to the continued weakening of the US dollar and the unexpected strengthening of the Swiss franc relative to both the US dollar and the euro by approximately 11 percent and 3 percent respectively.
 
Its shares were down 22.9 percent at $12 in afternoon trade on the Nasdaq. The stock had slipped as far as $11.60 earlier in the trading session.
The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.